CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 82 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,216 | +8.1% | 10,135 | -5.2% | 0.00% | 0.0% |
| Q3 2022 | $15,000 | -70.6% | 10,686 | -61.3% | 0.00% | -50.0% |
| Q2 2022 | $51,000 | -30.1% | 27,614 | +0.3% | 0.00% | -33.3% |
| Q1 2022 | $73,000 | -75.6% | 27,524 | -60.1% | 0.00% | -76.9% |
| Q4 2021 | $299,000 | -14.1% | 68,953 | +25.3% | 0.01% | -40.9% |
| Q2 2021 | $348,000 | +52.6% | 55,035 | +86.6% | 0.02% | +100.0% |
| Q1 2021 | $228,000 | +20.6% | 29,500 | +3.8% | 0.01% | +22.2% |
| Q3 2020 | $189,000 | -50.7% | 28,409 | -38.2% | 0.01% | -52.6% |
| Q2 2020 | $383,000 | +279.2% | 45,986 | +248.4% | 0.02% | +171.4% |
| Q1 2020 | $101,000 | – | 13,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |